內窺鏡狹窄管理市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

在預測期內，內窺鏡狹窄管理市場預計將以近 6.0% 的複合年增長率增長。

市場增長的主要驅動力是全球胃腸道 (GI) 和食道疾病患病率上升，例如炎症性腸病、胃食管反流病 (GERD)、心血管出血、胃腸道出血和肥胖以及糖尿病等其他慢性疾病人口老齡化 例如，根據國際胃腸道疾病基金會 2019 年發布的報告，GERD 影響了大約三分之一的總人口，需要有效治療，並正在推動全球市場增長。

主要市場趨勢

在內窺鏡狹窄管理市場，支架有望佔據最大市場份額

• 支架預計將在整個預測期內主導市場，因為技術進步提高了安全性和便利性，這些設備的採用率顯著增加。 由於其自膨脹和可生物降解的特性，它也直接歸因於醫療保健專業人員越來越喜歡它，這推動了全球內窺鏡狹窄管理市場的收入增長。
• 在最終用戶方面，醫院佔據了最高的市場份額，這可以歸因於以下因素：與醫院相關的疾病（例如埋藏的陰莖、腸易激綜合症和胃食管反流病）的數量不斷增加；對微創手術的偏好；飆升的偏好，有利的報銷政策以及在這些環境中增強的患者護理預計將推動對該細分市場的需求，並在預測期內推動全球內窺鏡狹窄管理。

北美在市場上占主導地位，預計在預測期內也會如此。

預計在整個預測期內，北美將主導整個內窺鏡狹窄管理市場。 這種優勢是由於糖尿病、肥胖症和其他需要有效管理這些狹窄的胃腸道疾病等慢性病的負擔不斷增加。 此外，一些因素，如完善的直接報銷政策和先進醫療基礎設施的可用性，可能有利於該地區的市場，在預測期內為其突出的全球市場收入份額做出貢獻。是的。

競爭格局

內窺鏡狹窄管理市場競爭適中，由幾家大型企業組成。 一些目前佔據市場主導地位的主要參與者正在與其他公司進行收購以鞏固其在全球的市場地位，而另一些則有助於快速準確地佈局。我們正在推出具有先進技術的新產品 例如，2018 年 9 月，Zavation Medical Products 通過收購收購了 Pan Medical U.S. Corp，後者提供了一套完整的微創系統，有望對整體市場增長產生積極影響。 目前主導市場的公司包括 Boston Scientific Corporation、CONMED Corporation、Hobbs Medical Inc、Cook Medical Inc 和 Merit Medical Systems。

其他好處

• Excel 格式的市場預測 (ME) 表
• 三個月的分析師支持

內容

第一章介紹

• 調查結果
• 調查假設
• 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

• 市場概覽
• 市場驅動因素
  • 老齡化人口的增加和胃腸道疾病患病率的增加
  • 推出配備先進技術的新產品並支持微創手術
• 市場製約因素
  • 昂貴的胃腸道內窺鏡手術和麻煩的還款方式
  • 缺乏接受過內窺鏡狹窄手術培訓的熟練醫療保健專業人員
• 波特的五力分析
  • 新進入者的威脅
  • 買方/消費者議價能力
  • 供應商的議價能力
  • 替代品的威脅
  • 競爭公司之間的敵對關係

第 5 章市場細分

• 類型
  • 球囊擴張器
  • 支架
  • 探條擴張器
• 申請
  • 食道
  • 膽道
  • 其他
• 最終用戶
  • 醫院
  • 門診手術中心
  • 其他
• 按地區
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 中東和非洲
    • 海灣合作委員會
    • 南非
    • 其他中東和非洲地區
  • 南美洲地區
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章競爭格局

• 公司簡介
  • Boston Scientific Corporation
  • Olympus Corporation
  • Becton, Dickinson and Company
  • Cook Group
  • CONMED Corporation
  • STERIS plc
  • Medi-Globe Corporation
  • Hobbs Medical Inc
  • PanMed US
  • Merit Medical Systems

第7章 市場機會今後動向

The endoscopic stricture management market studied was anticipated to grow with a CAGR of nearly 6.0%, during the forecast period. The major factors attributing to the growth of the market are rise in the global prevalence of gastrointestinal (GI) and esophageal disorders such as inflammatory bowel disease, gastroesophageal reflux disease (GERD), cardiac vessel bleedings, and gastrointestinal hemorrhages and other chronic diseases like obesity and diabetes with increasing geriatric population. For instance, according to the International Foundation for Gastrointestinal Disorders Report published in 2019, GERD affects about one-third of the total population necessitating effective treatment driving the growth of the global market.

Key Market Trends

Stents are Expected to Hold the Largest Market Share in the Endoscopic Stricture Management Market

• Stents are expected to dominate the market throughout the forecast period owing to the huge rise in the adoption of these devices due to their enhanced safety with technological advancements and increased convenience. Also, due to the rise in preference by the healthcare providers due to their self-expandable and bio-degradable nature which directly fuels the growth of global endoscopic stricture management market revenue.
• Based on the end-user, hospitals account for the highest market share which can be attributed to factors such as increased volume of hospital-associated diseases such as buried penis, IBS, GERD, etc., resultant rising demand for hospitals stays, steep upsurge in preference for minimally invasive surgical procedures, and favorable reimbursement policies along with enhanced patient care in these settings are expected to drive the demand for the segment and propel the global endoscopic stricture management during the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall endoscopic stricture management market throughout the forecast period. The dominance is due to the rise in chronic diseases such as diabetes and obesity, other GI disorders necessitating effective management of these strictures to decrease the rising burden. Also, several factors such as well-established direct reimbursement policies and the availability of advanced healthcare infrastructure may favor the market in this region contributing to its outstanding global market revenue share during the forecast period.

Competitive Landscape

The endoscopic stricture management market is moderately competitive and consists of several major players. Few of the major players currently dominating the market are making acquisitions with the other companies to consolidate their market positions across the globe and while others are launching new products with advanced technologies to facilitate fast and accurate placement. For instance, in September 2018, Zavation Medical Products acquired Pan Medical U.S. Corp through the acquisition, the company offers a full suite of minimally invasive systems which is expected to have a positive impact on the overall market growth. Some of the companies which are currently dominating the market are Boston Scientific Corporation, CONMED Corporation, Hobbs Medical Inc, Cook Medical Inc, and Merit Medical Systems

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Geriatric Popuation and Rise in Prevalence of GI Disorders
  • 4.2.2 New Product Launches with Advanced Technologies and Prefernce for Minimal Invasive Procedures
• 4.3 Market Restraints
  • 4.3.1 Highly Expensive GI Endoscopic Procedures and Troublesome Repayment Approaches
  • 4.3.2 Lack of Trained and Skilled Healthcare Professionals in Endoscopic Stricture Technology
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 Type
  • 5.1.1 Balloon Dilators
  • 5.1.2 Stents
  • 5.1.3 Bougie Dilators
• 5.2 Application
  • 5.2.1 Esophageal
  • 5.2.2 Biliary
  • 5.2.3 Others
• 5.3 End-User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Others
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Boston Scientific Corporation
  • 6.1.2 Olympus Corporation
  • 6.1.3 Becton, Dickinson and Company
  • 6.1.4 Cook Group
  • 6.1.5 CONMED Corporation
  • 6.1.6 STERIS plc
  • 6.1.7 Medi-Globe Corporation
  • 6.1.8 Hobbs Medical Inc
  • 6.1.9 PanMed US
  • 6.1.10 Merit Medical Systems

7 MARKET OPPORTUNITIES AND FUTURE TRENDS